### Accession
PXD001006

### Title
CPTAC System Suitability (CompRef) Study: Proteome, VU

### Description
The objective of the "System Suitability (CompRef) Study" was to validate mass spectrometry protocols used at each Proteome Characterization Center (PCC).  Please include this attribution in publications, "Data used in this publication was created by the Clinical Proteomics Tumor Analysis Consortium (NCI/NIH)."

### Sample Protocol
Analytical Sample Protocol - Alkylation: Iodoacetamide, Fractionation: Peptide IEF, Fractions: 15, Proteolysis: Trypsin, Starting Amount: 200 ug; Chromatography Protocol - Column Length: 11 cm, Column Type: C18, Gradient Length: 95 min, Injected: 1 ug, Inside Diameter: 100 um, Particle Size: 5 um, Particle Type: None; Mass Spectrometry Protocol - Collision Energy: None, Dissociation: CID, Instrument: Thermo LTQ Orbitrap Velos, MS1 Resolution: 60000, MS2 Resolution: None, Precursors: Top 8. See associated protocols and methods documents at https://cptac-data-portal.georgetown.edu.

### Data Protocol
Processed using the CPTAC Common Data Analysis Pipeline at NIST. Peptide identifications from MSGF+. Filtered at 1% FDR. See associated protocols and methods documents at https://cptac-data-portal.georgetown.edu.

### Publication Abstract
None

### Keywords
Cptac cptac-compref cptac-vu

### Affiliations
Georgetown University
Vanderbilt University

### Submitter
Nathan Edwards

### Lab Head
Dr Daniel C. Liebler, Ph.D.
Vanderbilt University


